Franchi, M.; Tritto, R.; Torroni, L.; Reno, C.; La Vecchia, C.; Corrao, G.
Effectiveness and Healthcare Cost of Adding Trastuzumab to Standard Chemotherapy for First-Line Treatment of Metastatic Gastric Cancer: A Population-Based Cohort Study. Cancers 2020, 12, 1691.
https://doi.org/10.3390/cancers12061691
AMA Style
Franchi M, Tritto R, Torroni L, Reno C, La Vecchia C, Corrao G.
Effectiveness and Healthcare Cost of Adding Trastuzumab to Standard Chemotherapy for First-Line Treatment of Metastatic Gastric Cancer: A Population-Based Cohort Study. Cancers. 2020; 12(6):1691.
https://doi.org/10.3390/cancers12061691
Chicago/Turabian Style
Franchi, Matteo, Roberta Tritto, Lorena Torroni, Chiara Reno, Carlo La Vecchia, and Giovanni Corrao.
2020. "Effectiveness and Healthcare Cost of Adding Trastuzumab to Standard Chemotherapy for First-Line Treatment of Metastatic Gastric Cancer: A Population-Based Cohort Study" Cancers 12, no. 6: 1691.
https://doi.org/10.3390/cancers12061691
APA Style
Franchi, M., Tritto, R., Torroni, L., Reno, C., La Vecchia, C., & Corrao, G.
(2020). Effectiveness and Healthcare Cost of Adding Trastuzumab to Standard Chemotherapy for First-Line Treatment of Metastatic Gastric Cancer: A Population-Based Cohort Study. Cancers, 12(6), 1691.
https://doi.org/10.3390/cancers12061691